Literature DB >> 11447085

Prognostic significance of endothelial dysfunction in hypertensive patients.

F Perticone1, R Ceravolo, A Pujia, G Ventura, S Iacopino, A Scozzafava, A Ferraro, M Chello, P Mastroroberto, P Verdecchia, G Schillaci.   

Abstract

BACKGROUND: Forearm endothelial dysfunction, characterized by an impaired vasodilating response to acetylcholine (ACh), may be associated with several cardiovascular risk factors, including essential hypertension. Although the prognostic value of coronary endothelial dysfunction has been demonstrated, that of forearm endothelial dysfunction is still unknown. Methods and Results-- Endothelium-dependent and -independent vasodilation was investigated in 225 never-treated hypertensive patients (age, 35 to 54 years) by intra-arterial infusion of increasing doses of ACh and sodium nitroprusside. Patients were divided into tertiles on the basis of their increase in ACh-stimulated forearm blood flow (FBF) from basal: group 1, from 30% to 184%; group 2, from 185% to 333%; and group 3, from 339% to 760% increase from basal. During a mean follow-up of 31.5 of months (range, 4 to 84 months), there were 29 major adverse events at the cardiac (n=19), cerebrovascular (n=9), or peripheral vascular (n=1) level. Events included myocardial infarction, angina, coronary revascularization procedures, stroke, transient cerebral ischemic attack, and aortoiliac occlusive disease. Event rate per 100 patient-years was 8.17, 4.34, and 2.02 in the first, second, and third tertiles of peak percent increase in FBF during ACh infusion. The excess risk associated with an FBF increase in the first tertile was significant (relative risk, 2.084; 95% CI, 1.25 to 3.48; P=0.0049) after controlling for individual risk markers, including 24-hour ambulatory blood pressure.
CONCLUSIONS: Our data suggest that forearm endothelial dysfunction is a marker of future cardiovascular events in patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447085     DOI: 10.1161/01.cir.104.2.191

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  225 in total

1.  Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting.

Authors:  Alenka Mavri; Peter Poredoš; David Suran; Benedicte Gaborit; Irène Juhan-Vague; Pavel Poredoš
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

2.  Relationship between upper and lower limb conduit artery vasodilator function in humans.

Authors:  Dick H J Thijssen; Nicola Rowley; Jaume Padilla; Grant H Simmons; M Harold Laughlin; Greg Whyte; N Timothy Cable; Daniel J Green
Journal:  J Appl Physiol (1985)       Date:  2011-04-21

3.  Endothelial function and cerebrovascular disease: implications for diagnosis and treatment.

Authors:  Ahmad A Elesber; Piero O Bonetti; Amir Lerman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

Review 4.  Exercise and the nitric oxide vasodilator system.

Authors:  Andrew Maiorana; Gerard O'Driscoll; Roger Taylor; Daniel Green
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

5.  Retrograde flow components in the brachial artery. A new hemodynamic index.

Authors:  Santiago Mc Loughlin; Mario Jorge Mc Loughlin; Francisco Azzato; Jose Milei
Journal:  Eur J Appl Physiol       Date:  2012-02-11       Impact factor: 3.078

6.  Association between hemoglobin level and endothelial function in uncomplicated, untreated hypertensive patients.

Authors:  Raffaele Maio; Angela Sciacqua; Rosamaria Bruni; Alessandra Pascale; Giuseppe Carullo; Paola E Scarpino; Desirée Addesi; Ines Spinelli; Giulia Galiano Leone; Francesco Perticone
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 8.237

7.  Brachial artery low-flow-mediated constriction is increased early after coronary intervention and reduces during recovery after acute coronary syndrome: characterization of a recently described index of vascular function.

Authors:  Jonathan R Spiro; Janet E Digby; Gopal Ghimire; Mark Mason; Andrew G Mitchell; Charles Ilsley; Ann Donald; Miles C D Dalby; Rajesh K Kharbanda
Journal:  Eur Heart J       Date:  2010-10-29       Impact factor: 29.983

8.  Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery.

Authors:  Alex L Huang; Annemarie E Silver; Elena Shvenke; David W Schopfer; Eiman Jahangir; Megan A Titas; Alex Shpilman; James O Menzoian; Michael T Watkins; Joseph D Raffetto; Gary Gibbons; Jonathan Woodson; Palma M Shaw; Mandeep Dhadly; Robert T Eberhardt; John F Keaney; Noyan Gokce; Joseph A Vita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-23       Impact factor: 8.311

Review 9.  The L-arginine-nitric oxide pathway in hypertension.

Authors:  Malte Kelm
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 10.  RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.

Authors:  Christian Werner; Magnus Baumhäkel; Koon K Teo; Roland Schmieder; Johannes Mann; Thomas Unger; Salim Yusuf; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2008-05-03       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.